EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Interpretable Deep Learning and Molecular Docking Framework for Repurposing Existing Drugs as Inhibitors of SARS-CoV-2 Main Protease

Juan Huang, Jialong Gao, Qu Chen iD

Molecules · 2025

DOI: 10.3390/molecules30163409 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2025. Verfasst von Juan Huang und 2 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Drug Repositioning, Deep Learning, SARS-CoV-2. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the widespread use of vaccines against SARS-CoV-2, COVID-19 continues to pose global health challenges, requiring efficient drug screening and repurposing strategies. This study presents a novel hybrid framework that integrates deep learning (DL) with molecular docking to accelerate the identification of potential therapeutics. The framework comprises three crucial steps: (1) a previously developed DL model is employed to rapidly screen candidate compounds, selecting those with predicted interaction scores above a cut-off value of 0.8; (2) AutoDock Vina version 1.5.6 and LeDock version 1.0 are used to evaluate binding affinities, with a threshold of

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Molecular Docking SimulationDrug RepositioningDeep LearningSARS-CoV-2Coronavirus 3C ProteasesCOVID-19 Drug TreatmentAntiviral AgentsProtease InhibitorsHumansBinding SitesCOVID-19Protein Binding

Stichwörter der Autor:innen

SARS-CoV-2 main proteaseattention mechanismdeep learningdrug repurposingmolecular docking

Substanzen

Coronavirus 3C ProteasesAntiviral AgentsProtease Inhibitors3C-like proteinase, SARS-CoV-2

Autor:innen und Institutionen

  • School of Biological and Chemical Engineering, Zhejiang University of Science and Technology, Hangzhou 310023, China.

ORCID-Profile: Qu Chen

Förderung

  • Zhejiang Provincial Natural Science Foundation

Zitieren

APA

Huang, J., Gao, J., & Chen, Q. (2025). An Interpretable Deep Learning and Molecular Docking Framework for Repurposing Existing Drugs as Inhibitors of SARS-CoV-2 Main Protease. Molecules. https://doi.org/10.3390/molecules30163409

Vancouver

Huang J, Gao J, Chen Q. An Interpretable Deep Learning and Molecular Docking Framework for Repurposing Existing Drugs as Inhibitors of SARS-CoV-2 Main Protease. Molecules. 2025. doi:10.3390/molecules30163409

BibTeX
@article{Huang2025,
  author = {Huang, Juan and Gao, Jialong and Chen, Qu},
  title = {An Interpretable Deep Learning and Molecular Docking Framework for Repurposing Existing Drugs as Inhibitors of SARS-CoV-2 Main Protease},
  journal = {Molecules},
  year = {2025},
  doi = {10.3390/molecules30163409}
}
Kostenlos starten →